PA8572901A1 - NEW DERIVATIVES OF INDOL AS INHIBITORS OF FACTOR XA - Google Patents
NEW DERIVATIVES OF INDOL AS INHIBITORS OF FACTOR XAInfo
- Publication number
- PA8572901A1 PA8572901A1 PA8572901A PA8572901A PA8572901A1 PA 8572901 A1 PA8572901 A1 PA 8572901A1 PA 8572901 A PA8572901 A PA 8572901A PA 8572901 A PA8572901 A PA 8572901A PA 8572901 A1 PA8572901 A1 PA 8572901A1
- Authority
- PA
- Panama
- Prior art keywords
- factor
- compounds
- formula
- new derivatives
- presented
- Prior art date
Links
Abstract
NUEVOS DERIVADOS LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA I EN LA QUE R0; R1; R2; R3; R4; R5; R6; R7; Q; V; G; Y M POSEEN LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES. LOS COMPUESTOS DE LA FORMULA I SON COMPUESTOS VALIOSOS, FARMACOLOGICAMENTE ACTIVOS. ESTOS COMPUESTOS PONEN DE MANIFIESTO UN FUERTE EFECTO ANTITROMBOLICO Y SON ADECUADOS, POR EJEMPLO, PARA EL TRATAMIENTO TERAPEUTICO Y LA PROFILAXIS DE TRASTORNOS CARDIOVASCULARES TALES COMO ENFERMEDADES TROMBOEMBOLICAS O RESTENOSIS. LOS COMPUESTOS SON INHIBIDORES REVERSIBLES DE LAS ENZIMAS DE LA COAGULACION SANGUINEA FACTOR XA (FXa) Y/O FACTOR VLLA (FVLLA) Y, EN GENERAL, PUEDEN SER APLICADOS EN CONDICIONES EN LAS QUE SE ENCUENTRA PRESENTE UNA ACTIVIDAD INDESEADA DE FACTOR XA Y/O DE FACTOR VLLA O PARA LA CURACION O PREVENCION DE LA CUAL SE PRESENTA UN INHIBICION DE FACTOR XA Y/O DEL FACTOR VLLA. LA INVENCION SE REFIERE, ADEMAS, A PROECEDIMIENTOS DE PREPARACION DE COMPUESTOS DE LA FORMULA 1, A SU USO, EN PARTICULAR COMO INGREDIENTES ACTIVOS EN PRODUCTOS FARMACEUTICOS, Y A PREPARACIONES FARMACEUTICAS QUE LO CONTIENEN.NEW DERIVATIVES THE PRESENT INVENTION REFERS TO COMPOUNDS OF FORMULA I IN WHICH R0; R1; R2; R3; R4; R5; R6; R7; Q; V; G; AND M HAVE THE MEANINGS INDICATED IN THE CLAIMS. THE COMPOUNDS OF FORMULA I ARE VALUABLE, PHARMACOLOGICALLY ACTIVE COMPOUNDS. THESE COMPOUNDS MANIFEST A STRONG ANTHROMBOLIC EFFECT AND ARE ADEQUATE, FOR EXAMPLE, FOR THERAPEUTIC TREATMENT AND PROFILAXIS OF CARDIOVASCULAR DISORDERS SUCH AS THROMBOEMBOLIC DISEASES OR RESTENOSIS. THE COMPOUNDS ARE REVERSIBLE INHIBITORS OF THE ENGAGEMENTS OF THE SANGUINEA COAGULATION FACTOR XA (FXa) AND / OR FACTOR VLLA (FVLLA) AND, IN GENERAL, MAY BE APPLIED IN CONDITIONS IN WHICH AN INDENATED ACTIVITY OF OACTOR XA AND FACTOR IS PRESENTED OF FACTOR VLLA OR FOR THE HEALING OR PREVENTION OF WHICH AN INHIBITION OF FACTOR XA AND / OR FACTOR VLLA IS PRESENTED. THE INVENTION REFERS, IN ADDITION, TO PROCEDURES FOR THE PREPARATION OF COMPOUNDS OF FORMULA 1, FOR USE, IN PARTICULAR AS ACTIVE INGREDIENTS IN PHARMACEUTICAL PRODUCTS, AND PHARMACEUTICAL PREPARATIONS CONTAINING IT.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PA8572901A PA8572901A1 (en) | 2003-05-05 | 2003-05-05 | NEW DERIVATIVES OF INDOL AS INHIBITORS OF FACTOR XA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PA8572901A PA8572901A1 (en) | 2003-05-05 | 2003-05-05 | NEW DERIVATIVES OF INDOL AS INHIBITORS OF FACTOR XA |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8572901A1 true PA8572901A1 (en) | 2004-11-26 |
Family
ID=40257255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA8572901A PA8572901A1 (en) | 2003-05-05 | 2003-05-05 | NEW DERIVATIVES OF INDOL AS INHIBITORS OF FACTOR XA |
Country Status (1)
Country | Link |
---|---|
PA (1) | PA8572901A1 (en) |
-
2003
- 2003-05-05 PA PA8572901A patent/PA8572901A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP045115A (en) | INDOL-2-CARBOXAMIDS AS FACTOR INHIBITORS Xa | |
UY28778A1 (en) | PIRROL DERIVATIVES AS INHIBITORS OF FACTOR XA | |
PA8624901A1 (en) | DERIVATIVES OF BETA-AMINOACIDOS AS INHIBITORS OF THE FACTOR Xa | |
MX2008013836A (en) | 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
NO20050851L (en) | Caspase Inhibitors and Uses thereof | |
EA201000365A1 (en) | HETEROCYCLIC AMIDES SUITABLE FOR THE TREATMENT OF MALIGNANT NORMAL FORMATION AND PSORIASIS | |
NO20055421L (en) | Quinoline derivatives as phosphodiesterase inhibitors | |
SG170101A1 (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
ATE453636T1 (en) | SUBSTITUTED 2,3-DIHYDRO-1H-ISOINDOL-1-ONE DERIVATIVES AND METHODS OF USE | |
CU23208A3 (en) | OXAZOLIDINONAS REPLACED AND ITS USE IN THE FIELD OF THE SANGUINEA COAGULATION | |
SV2010003491A (en) | 2- ANILINOPURIN-8-ONAS AS INHIBITORS OF TTK / MPS1 FOR THE TREATMENT OF PROLIFERATIVE DISORDERS | |
IS8175A (en) | Piperazine derivatives and methods of their use | |
CY1108932T1 (en) | Compounds 4- (heterocyclyl) -benzenesulfoximine for the therapeutic treatment of inflammatory diseases | |
EA200601212A1 (en) | PHOSPHODESTERASE INHIBITORS, OBTAINING AND THEIR THERAPEUTIC APPLICATION | |
HN2004000232A (en) | "PIRROLO DERIVATIVES (3,4-C) PIRAZOL ACTIVE AS QUINASE INHIBITORS, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM." | |
MX2014003408A (en) | N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e] [1,3]oxazin-4-yl)-phenyl)-amides as bace1 inhibitors. | |
MX2008008556A (en) | Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases. | |
UY29239A1 (en) | NEW DERIVATIVES OF PYRIDOTIENOPIRIMIDINE | |
ATE367387T1 (en) | USE OF OXINDOL DERIVATIVES FOR THE TREATMENT OF DEMENTIA-RELATED DISEASES, ALZHEIMER'S DISEASE AND GLYCOGEN SYNTHASE KINASE-3-ASSOCIATED CONDITIONS | |
AR052413A1 (en) | NEW DERIVATIVES OF PYRIDOTIENOPIRIIDINE | |
UY30029A1 (en) | DERIVATIVES OF PIPERIDINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
ATE444069T1 (en) | QUINOLINE DERIVATIVES FOR THE TREATMENT OF MGLUR5 RECEPTOR-MEDIATED DISEASES | |
ECSP056178A (en) | BENCIMIDAZOL DERIVATIVES AS INHIBITORS OF FACTOR XA | |
PA8816101A1 (en) | CHLOROPHYPHENE - AMIDAS AS INHIBITORS OF THE XA AND THROMBINE COAGULATION FACTORS | |
NO20090067L (en) | Pharmaceutical combinations for the treatment of respiratory diseases |